https://www.avient.com/sites/default/files/2021-07/lactra-low-tio2-product-bulletin_0.pdf
TECHNOLOGY BENEFITS
• Improved light blocking performance up
to 99.9% at 550nm and 700nm
• Brighter whiteness L* >90 even in thin wall
sections (0.21mm)
• Plug & go solution—processes similar to
virgin PET
• Process with standard PET grades and rPET
• Reduces equipment wear and tear
• TiO
2
content of
https://www.avient.com/idea/discover-tpes-healthcare
We're dedicated to providing the healthcare industry with innovative thermoplastic elastomers (TPEs) that offer design freedom, regulatory compliance confidence, and system optimization.
https://www.avient.com/stan-tone-fsp-silicone-paste-dispersions
Approved for USP Class VI compliance.
https://www.avient.com/company/sustainability/sustainability-report/people/ehs
Their primary focus is to ensure risk management systems are meeting regulatory compliance and operational excellence globally.
https://www.avient.com/products/polymer-colorants/colorant-dispersions/stan-tone-rbx-rubber-dispersions
Approved for USP Class VI compliance.
https://www.avient.com/idea/rise-above-four-common-lightweighting-mistakes
Generally, replacing a metal component with a plastic one results in a 50 percent weight reduction, so the math is attractive to designers striving to reach Corporate Average Fuel Economy (CAFE) targets.
https://www.avient.com/products/polymer-colorants/high-temperature-color-concentrates/colorant-chromatics-transcend-biocompatible-peek-pre-colored-compounds
Global Reach: With qualified production plants in Asia, Europe, and America, we provide local supply and technical support to meet your needs.
https://www.avient.com/products/engineered-polymer-formulations/conductive-signal-radiation-shielding-formulations/colorant-chromatics-conductive-formulations-0
Reach out to our experienced technical experts to find the right solution for your application.
https://www.avient.com/news/polyone-announces-launch-innovative-specialty-technology-serve-healthcare-industry
Our healthcare solutions portfolio continues to grow, as does our mix in this important industry, where last year company revenues from healthcare reached $413 million, as compared to $103 million in 2006.”
https://www.avient.com/news/polyone-shareholders-approve-all-proposals-2015-annual-meeting
Director Gordon Harnett was not up for re-election, having reached the company’s required retirement age.